Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5446 to 5460 of 7681 results

  1. Frequency and duration of endoscopic follow-up: What is the optimal frequency and duration of endoscopic follow-up for patients who have received endoscopic treatment for Barrett's oesophagus with dysplasia?

    Recommendation ID NG231/05A Question Frequency and duration of endoscopic follow-up: What is the optimal frequency and duration of endoscopic

  2. Frequency and duration of endoscopic follow-up: What is the optimal frequency and duration of endoscopic follow-up for patients who have received endoscopic treatment for stage 1 oesophageal adenocarcinoma?

    Recommendation ID NG231/05B Question Frequency and duration of endoscopic follow-up: What is the optimal frequency and duration of endoscopic

  3. Self-monitoring of blood glucose levels: What is the optimal frequency for self‑monitoring of blood glucose in adults with type 2 diabetes?

    Recommendation ID NG28/05 Question Self-monitoring of blood glucose levels: What is the optimal frequency for self‑monitoring of blood

  4. What is the optimal frequency, intensity and form of rehabilitation for mobility problems in people with Multiple Sclerosis (MS)?

    Recommendation ID CG186/3 Question What is the optimal frequency, intensity and form of rehabilitation for mobility problems in people

  5. Histological margins: What is the optimal histological excision margin in stage 0 melanoma?

    Recommendation ID NG14/04 Question Histological margins: What is the optimal histological excision margin in stage 0 melanoma? Any

  6. Cardiac MRI versus other imaging techniques for diagnosing heart failure:- What is the optimal imaging technique for the diagnosis of heart failure?

    Recommendation ID NG106/2 Question Cardiac MRI versus other imaging techniques for diagnosing heart failure:- What is the optimal imaging

  7. Management of anaemia of CKD with concurrent illness: What is the optimal management (in terms of clinical and cost effectiveness) of anaemia of CKD in people who are receiving erythropoietic stimulating agents (ESAs) and have a significant concurrent acute infectious illness?

    Recommendation ID NG203/22 Question Management of anaemia of CKD with concurrent illness: What is the optimal management (in terms of clinical

  8. The impact of atrial fibrillation on the natriuretic peptide threshold for diagnosing heart failure:- What is the optimal NT-proBNP threshold for the diagnosis of heart failure in people with atrial fibrillation?

    Recommendation ID NG106/3 Question The impact of atrial fibrillation on the natriuretic peptide threshold for diagnosing heart failure:- What

  9. Length of bed rest after spinal cord injury: What is the effectiveness and cost effectiveness of short-term bed rest compared with long-term bed rest on functional outcomes in people with complex rehabilitation needs after traumatic injury that involves the spinal column or spinal cord injury?

    Recommendation ID NG211/05 Question Length of bed rest after spinal cord injury: What is the effectiveness and cost effectiveness of short-term

  10. What is the effectiveness and safety of a treatment dose with a low molecular weight heparin (LMWHs) compared with a standard prophylactic dose for venous thromboembolism (VTE) prophylaxis in young people under 18 years with COVID-19?

    Recommendation ID NG191/3 Question What is the effectiveness and safety of a treatment dose with a low molecular weight heparin (LMWHs)

  11. What is the effectiveness and safety of extended pharmacological venous thromboembolism (VTE) prophylaxis for people who have been discharged after treatment for COVID-19?

    Recommendation ID NG191/2 Question What is the effectiveness and safety of extended pharmacological venous thromboembolism (VTE) prophylaxis

  12. What is the effectiveness and safety of neutralising monoclonal antibodies against different SARS-CoV-2 variants?

    Recommendation ID NG191/15 Question What is the effectiveness and safety of neutralising monoclonal antibodies against different SARS-CoV-2

  13. What is the effectiveness and safety of standard-dose compared with intermediate-dose pharmacological venous thromboembolism (VTE) prophylaxis for people with COVID-19, with or without additional risk factors for VTE?

    Recommendation ID NG191/1 Question What is the effectiveness and safety of standard-dose compared with intermediate-dose pharmacological

  14. Advocacy and support for decision-making:- What is the effectiveness, cost effectiveness and acceptability of advocacy as a means of supporting people to make decisions?

    Recommendation ID NG108/3 Question Advocacy and support for decision-making:- What is the effectiveness, cost effectiveness and acceptability